Perspective Therapeutics, Inc.·4

Mar 4, 4:35 PM ET

Hunt Jonathan Robert 4

4 · Perspective Therapeutics, Inc. · Filed Mar 4, 2026

Insider Transaction Report

Form 4
Period: 2026-03-02
Hunt Jonathan Robert
Chief Accounting Officer
Transactions
  • Award

    Stock option (right to buy)

    [F1][F2]
    2026-03-02+90,00090,000 total
    Exercise: $5.35Exp: 2036-03-02Common Stock (90,000 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Compensation Committee of the Issuer's Board of Directors on February 4, 2026, with a grant date of March 2, 2026 (the "Grant Date"), and represents the Reporting Person's annual equity award for 2026.
  • [F2]Option vests and becomes exercisable over four years in 48 substantially equal monthly installments beginning on the date that is one month after the Grant Date, subject to the Reporting Person's continued service on each vesting date.
Signature
/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact|2026-03-04

Documents

1 file
  • 4
    ownership.xmlPrimary

    4